Friday, May 2, 2008

procarbazine

Sensitivity to procarbazine
»Caution should be used also in patients who have had previous cytotoxic drug therapy or radiation therapy. »In addition, caution should be used in patients who have undergone sympathectomy, who may be more sensitive to the hypotensive effects of MAO inhibitors.

Other medical problems, especially active alcoholism, bone marrow depression, cardiac arrhythmias, chickenpox or recent exposure, congestive heart failure, coronary insufficiency, severe or frequent headaches, hepatic function impairment, herpes zoster, other infection, paranoid schizophrenia or other hyperexcitable personality states, pheochromocytoma, sympathectomy, or renal function impairment


Indications
Systemic

Lymphomas, Hodgkin's (treatment) or [Lymphomas, non-Hodgkin's (treatment)]

Procarbazine is indicated, in combination with other agents, for treatment of Hodgkin's disease (Stage III and IV) and some non-Hodgkin's lymphomas .
[Tumors, brain, primary (treatment)]

Procarbazine is indicated for treatment of primary brain tumors .
[Multiple myeloma (treatment)]

Procarbazine is indicated for treatment of multiple myeloma.